NCT04410900View on ClinicalTrials.gov

Vaccine Responsiveness After CAR-T Cell Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

August 3, 2020

Primary Completion Date

April 28, 2025

Study Completion Date

August 31, 2025

Conditions
B-Cell Neoplasm
Interventions
BIOLOGICAL

Wistar Rabies Virus Strain PM-1503-3M Vaccine

Given IM

PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
lead

Fred Hutchinson Cancer Center

OTHER

NCT04410900 - Vaccine Responsiveness After CAR-T Cell Therapy | Biotech Hunter | Biotech Hunter